These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 33165928)

  • 41. Circulating tumour DNA for clinicians: current and future clinical applications.
    Thompson MK; Gale D; Brenton JD
    Clin Radiol; 2021 Oct; 76(10):737-747. PubMed ID: 34389159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
    Valpione S; Campana L
    Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
    Merker JD; Oxnard GR; Compton C; Diehn M; Hurley P; Lazar AJ; Lindeman N; Lockwood CM; Rai AJ; Schilsky RL; Tsimberidou AM; Vasalos P; Billman BL; Oliver TK; Bruinooge SS; Hayes DF; Turner NC
    J Clin Oncol; 2018 Jun; 36(16):1631-1641. PubMed ID: 29504847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
    Ponti G; Manfredini M; Tomasi A
    Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
    Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R
    J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating cell-free tumor DNA analysis in pediatric cancers.
    Andersson D; Fagman H; Dalin MG; Ståhlberg A
    Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liquid biopsy enters the clinic - implementation issues and future challenges.
    Ignatiadis M; Sledge GW; Jeffrey SS
    Nat Rev Clin Oncol; 2021 May; 18(5):297-312. PubMed ID: 33473219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation.
    Rolfo CD; Madison RW; Pasquina LW; Brown DW; Huang Y; Hughes JD; Graf RP; Oxnard GR; Husain H
    Clin Cancer Res; 2024 Jun; 30(11):2452-2460. PubMed ID: 38526394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Circulating Tumor DNA in Lung Cancer: Mutational Analysis, Diagnosis, and Surveillance Now and into the Future.
    Scilla KA; Rolfo C
    Curr Treat Options Oncol; 2019 Jun; 20(7):61. PubMed ID: 31203467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management.
    Wang B; Wang M; Lin Y; Zhao J; Gu H; Li X
    Clin Chem Lab Med; 2024 Oct; 62(11):2111-2127. PubMed ID: 38443752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine.
    Batth IS; Mitra A; Manier S; Ghobrial IM; Menter D; Kopetz S; Li S
    Ann Oncol; 2017 Mar; 28(3):468-477. PubMed ID: 27998963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.
    Rossi D; Kurtz DM; Roschewski M; Cavalli F; Zucca E; Wilson WH
    Hematol Oncol; 2020 Feb; 38(1):34-37. PubMed ID: 31872890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer.
    Chamberlin MD; Wells JD; Shee K; Bean JR; Marotti JD; Wells WA; Trask HW; Kolling FW; Bhatt A; Kaufman PA; Schwartz GN; Gemery JM; McNulty NJ; Tsapakos MJ; Barth RJ; Arrick BA; Gui J; Miller TW
    Breast Cancer Res Treat; 2020 Aug; 182(3):665-677. PubMed ID: 32562118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients.
    Schwaederle M; Husain H; Fanta PT; Piccioni DE; Kesari S; Schwab RB; Patel SP; Harismendy O; Ikeda M; Parker BA; Kurzrock R
    Clin Cancer Res; 2016 Nov; 22(22):5497-5505. PubMed ID: 27185373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Circulating Tumor DNA (ctDNA) Detection Using BEAMing and Its Clinical Significance.].
    Nakamura K
    Rinsho Byori; 2016 May; 64(4):400-406. PubMed ID: 29182806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma.
    Egyud M; Tejani M; Pennathur A; Luketich J; Sridhar P; Yamada E; Ståhlberg A; Filges S; Krzyzanowski P; Jackson J; Kalatskaya I; Jiao W; Nielsen G; Zhou Z; Litle V; Stein L; Godfrey T
    Ann Thorac Surg; 2019 Aug; 108(2):343-349. PubMed ID: 31059681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
    Giannopoulou L; Kasimir-Bauer S; Lianidou ES
    Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond.
    Keller L; Belloum Y; Wikman H; Pantel K
    Br J Cancer; 2021 Jan; 124(2):345-358. PubMed ID: 32968207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer.
    El Achi H; Khoury JD; Loghavi S
    Curr Hematol Malig Rep; 2019 Oct; 14(5):358-367. PubMed ID: 31346903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.
    Gómez-Peregrina D; Cicala CM; Serrano C
    Curr Opin Oncol; 2024 Jul; 36(4):282-290. PubMed ID: 38726808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.